Correlation Between Veracyte and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Veracyte and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Veracyte and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Veracyte and Kymera Therapeutics, you can compare the effects of market volatilities on Veracyte and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Veracyte with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Veracyte and Kymera Therapeutics.
Diversification Opportunities for Veracyte and Kymera Therapeutics
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Veracyte and Kymera is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Veracyte and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Veracyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Veracyte are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Veracyte i.e., Veracyte and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Veracyte and Kymera Therapeutics
Given the investment horizon of 90 days Veracyte is expected to generate 1.18 times less return on investment than Kymera Therapeutics. But when comparing it to its historical volatility, Veracyte is 1.56 times less risky than Kymera Therapeutics. It trades about 0.09 of its potential returns per unit of risk. Kymera Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 3,914 in Kymera Therapeutics on October 20, 2024 and sell it today you would earn a total of 147.00 from holding Kymera Therapeutics or generate 3.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Veracyte vs. Kymera Therapeutics
Performance |
| Timeline |
| Veracyte |
| Kymera Therapeutics |
Veracyte and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Veracyte and Kymera Therapeutics
The main advantage of trading using opposite Veracyte and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Veracyte position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Veracyte vs. Crinetics Pharmaceuticals | Veracyte vs. Viridian Therapeutics | Veracyte vs. Cytokinetics | Veracyte vs. Structure Therapeutics American |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |